169 related articles for article (PubMed ID: 38114423)
1. CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus.
Taubmann J; Müller F; Yalcin Mutlu M; Völkl S; Aigner M; Bozec A; Mackensen A; Grieshaber-Bouyer R; Schett G
Arthritis Rheumatol; 2024 Apr; 76(4):497-504. PubMed ID: 38114423
[TBL] [Abstract][Full Text] [Related]
2. Autologous CD19-Targeted Chimeric Antigen Receptor (CAR)T-Cells as the Future of Systemic Lupus Erythematosus Treatment.
Kambayana G; Surya Rini S
Curr Rheumatol Rev; 2023 Jun; 19(3):260-269. PubMed ID: 36786138
[TBL] [Abstract][Full Text] [Related]
3. Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine Production.
Dingfelder J; Aigner M; Taubmann J; Minopoulou I; Park S; Kaplan CD; Cheng JK; Van Blarcom T; Schett G; Mackensen A; Lutzny-Geier G
Transplant Cell Ther; 2024 Jun; 30(6):582.e1-582.e10. PubMed ID: 38548226
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.
Mackensen A; Müller F; Mougiakakos D; Böltz S; Wilhelm A; Aigner M; Völkl S; Simon D; Kleyer A; Munoz L; Kretschmann S; Kharboutli S; Gary R; Reimann H; Rösler W; Uderhardt S; Bang H; Herrmann M; Ekici AB; Buettner C; Habenicht KM; Winkler TH; Krönke G; Schett G
Nat Med; 2022 Oct; 28(10):2124-2132. PubMed ID: 36109639
[TBL] [Abstract][Full Text] [Related]
5. Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus.
Kretschmann S; Völkl S; Reimann H; Krönke G; Schett G; Achenbach S; Lutzny-Geier G; Müller F; Mougiakakos D; Dingfelder J; Flamann C; Hanssens L; Gary R; Mackensen A; Aigner M
Transplant Cell Ther; 2023 Jan; 29(1):27-33. PubMed ID: 36241147
[TBL] [Abstract][Full Text] [Related]
6. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
7. CAR T-cell therapy in autoimmune diseases.
Schett G; Mackensen A; Mougiakakos D
Lancet; 2023 Nov; 402(10416):2034-2044. PubMed ID: 37748491
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus.
Jin X; Xu Q; Pu C; Zhu K; Lu C; Jiang Y; Xiao L; Han Y; Lu L
Cell Mol Immunol; 2021 Aug; 18(8):1896-1903. PubMed ID: 32472023
[TBL] [Abstract][Full Text] [Related]
9. Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.
Kansal R; Richardson N; Neeli I; Khawaja S; Chamberlain D; Ghani M; Ghani QU; Balazs L; Beranova-Giorgianni S; Giorgianni F; Kochenderfer JN; Marion T; Albritton LM; Radic M
Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842314
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus.
De Groof A; Hémon P; Mignen O; Pers JO; Wakeland EK; Renaudineau Y; Lauwerys BR
Clin Rev Allergy Immunol; 2017 Oct; 53(2):181-197. PubMed ID: 28500565
[TBL] [Abstract][Full Text] [Related]
11. [BCMA and autoantibody-producing RP105 B cells; possible new targets of B cell therapy in systemic lupus erythematosus].
Koarada S; Tashiro S; Suematsu R; Inoue H; Ohta A; Tada Y
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):38-45. PubMed ID: 22374441
[TBL] [Abstract][Full Text] [Related]
12. CD19
Xiong H; Tang Z; Xu Y; Shi Z; Guo Z; Liu X; Tan G; Ai X; Guo Q
Adv Rheumatol; 2022 Dec; 62(1):48. PubMed ID: 36494762
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus.
Doglio M; Ugolini A; Bercher-Brayer C; Camisa B; Toma C; Norata R; Del Rosso S; Greco R; Ciceri F; Sanvito F; Casucci M; Manfredi AA; Bonini C
Nat Commun; 2024 Mar; 15(1):2542. PubMed ID: 38538608
[TBL] [Abstract][Full Text] [Related]
14. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
15. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
[TBL] [Abstract][Full Text] [Related]
16. Patients with systemic lupus erythematosus show increased proportions of CD19
Zhu Q; Li Y; Zhang L; Wang M; Chen Z; Shi J; Li J; Li B; Li Z; Wang Y; Xie C
Clin Rheumatol; 2021 Jan; 40(1):151-165. PubMed ID: 32542581
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.
Jacob N; Stohl W
Autoimmunity; 2010 Feb; 43(1):84-97. PubMed ID: 20014977
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target.
Lou H; Ling GS; Cao X
J Autoimmun; 2022 Oct; 132():102861. PubMed ID: 35872103
[TBL] [Abstract][Full Text] [Related]
19. The immunological basis of B-cell therapy in systemic lupus erythematosus.
Mok MY
Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
[TBL] [Abstract][Full Text] [Related]
20. B-cell depletion in autoimmune diseases.
Schett G; Nagy G; Krönke G; Mielenz D
Ann Rheum Dis; 2024 Jun; ():. PubMed ID: 38777374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
